Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression during multistage hepatocarcinogenesis.

H C Pitot1, D G Beer, S Hendrich

  • 1Dept. of Oncology, Medical School, University of Wisconsin, Madison 53706.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.

Oncogene·2015
Same author

Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.

Oncogene·2011
Same author

Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma.

Oncogene·2005
Same author

Blood level of phosphoglycerate kinase does not correlate with presence or extent of tumor.

The International journal of biological markers·2004
Same author

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

The American journal of pathology·2001
Same author

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Researchers developed a multistage rat model for hepatocarcinogenesis, identifying initiation, promotion, and progression stages. Proto-oncogene activation, specifically c-raf-1, may indicate preneoplastic lesions that could become malignant.

Area of Science:

  • Hepatocarcinogenesis research
  • Oncology
  • Molecular biology

Background:

  • Multistage models of hepatocarcinogenesis in rats are crucial for studying liver cancer development.
  • Understanding the distinct stages of cancer progression is essential for effective therapeutic strategies.

Purpose of the Study:

  • To delineate and quantitate the distinct stages of hepatocarcinogenesis: initiation, promotion, and progression.
  • To investigate the potential of proto-oncogene transcriptional activation as a biomarker for preneoplastic lesions with malignant potential.

Main Methods:

  • Development and utilization of a multistage rat model for hepatocarcinogenesis.
  • Characterization of preneoplastic lesions using marker enzymes.
  • Analysis of proto-oncogene transcriptional activation, focusing on c-raf-1.

Related Experiment Videos

Main Results:

  • Successfully delineated three distinct stages: initiation (irreversible), promotion (reversible), and progression (irreversible).
  • Preliminary data suggest that transcriptional activation of proto-oncogenes, particularly c-raf-1, correlates with preneoplastic lesions.
  • Identified c-raf-1 activation as a potential indicator for lesions that may progress to malignancy.

Conclusions:

  • The developed rat model allows for the quantitation of distinct hepatocarcinogenesis stages.
  • Transcriptional activation of c-raf-1 proto-oncogene shows promise as a predictive biomarker for malignant transformation in preneoplastic liver lesions.